PEMPHIGOID GESTATIONIS : REPORT CASE AND LITERATURE REVIEW
Author(s) -
Benmouna Imane,
Cherradi Soukaina,
Amina Lakhdar,
Najia Zeraidi,
Aziz Baidada
Publication year - 2022
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/14319
Subject(s) - medicine , rash , dermatology , pregnancy , bullous pemphigoid , immunology , antibody , biology , genetics
Pemphigoid gestationis is a gravidic dermatosis usually appearing between the 28th and 32nd week of amenorrhea. The rash is pruritic, bullous or vesiculopapular and of periumbilical topography. In addition to clinical findings, Thediagnosis is confirmed by direct immunofluorescence. If local treatment fails, systemic corticosteroid therapy should be administered. Oral corticosteroids are the therapeutic mainstay in pregnancy and postpartum.. Consequences may be maternal (threat of premature delivery), fetal (intrauterine growth retardation), and neonatal (skin rash). Through this observation and a review of theliterature the authors will try to focus on the physiopathology, clinicalprofile, immunological diagnosis, treatment and evolution of PG.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom